What is the current annual EBITDA of BNTX?

As of today, BNTX annual EBITDA is -$300.99M

What is 1-year change in BNTX annual EBITDA?

BNTX annual EBITDA is up +19.44% year-over-year

What is 3-year change in BNTX annual EBITDA?

BNTX annual EBITDA is down -101.87% over the past 3 years

How far is BNTX annual EBITDA from its all-time high?

BNTX annual EBITDA is currently -101.44% below its historical high of $20.93B set on December 31, 2021

How does BNTX annual EBITDA rank versus sector peers?

BNTX annual EBITDA is higher than 4.15% of companies in Healthcare sector

When is BNTX next annual earnings release?

As of today, the next annual earnings release for BNTX has not been scheduled

What is the current quarterly EBITDA of BNTX?

As of today, BNTX quarterly EBITDA is -$551.24M

What is BNTX quarterly EBITDA most recent change?

BNTX quarterly EBITDA was up +12.71% on June 30, 2026

What is 1-year change in BNTX quarterly EBITDA?

BNTX quarterly EBITDA is up +1.89% year-over-year

How far is BNTX quarterly EBITDA from its all-time high?

BNTX quarterly EBITDA is currently -110.26% below its historical high of $5.37B set on September 30, 2021

How does BNTX quarterly EBITDA rank versus sector peers?

BNTX quarterly EBITDA is higher than 0.19% of companies in Healthcare sector

When is BNTX next earnings release?

The next earnings release for BNTX is on November 3, 2026

What is the current TTM EBITDA of BNTX?

As of today, BNTX TTM EBITDA is -$373.29M

What is BNTX TTM EBITDA most recent change?

BNTX TTM EBITDA was up +2.76% on June 30, 2026

What is 1-year change in BNTX TTM EBITDA?

BNTX TTM EBITDA is down -49.13% year-over-year

How far is BNTX TTM EBITDA from its all-time high?

BNTX TTM EBITDA is currently -101.79% below its historical high of $20.91B set on March 31, 2022

How does BNTX TTM EBITDA rank versus sector peers?

BNTX TTM EBITDA is higher than 3.04% of companies in Healthcare sector

When is BNTX next earnings release?

The next earnings release for BNTX is on November 3, 2026

BioNTech SE (BNTX) EBITDA History & Chart Since 2017

Annual EBITDA

-$300.99M$72.62M+19.44%

December 31, 2025

Summary

Current Value: As of today, BNTX annual EBITDA is -$300.99M, up +19.44% on December 31, 2025
Historical Performance: BNTX annual EBITDA is down -101.87% over the past 3 years, down -15.88% over the past 5 years
All-Time High Comparison: BNTX annual EBITDA is currently -101.44% below its historical high of $20.93B set on December 31, 2021
3-Year Low Comparison: BNTX annual EBITDA is +19.44% above its 3-year low of -$373.62M reached on December 31, 2024
Sector Comparison: BNTX annual EBITDA is higher than 4.15% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

BNTX Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	-$300.99M	+19.4%	-101.9%	-15.9%	–
Quarterly EBITDA	Jun 30, 26	-$551.24M	+1.9%	-6.1%	-110.9%	-2807.9%
TTM EBITDA	Jun 30, 26	-$373.29M	-49.1%	-106.1%	-105.5%	-1869.2%
Price	Aug 27, 26	$111.40	+9.3%	-7.7%	-68.9%	–
PE Ratio	Aug 27, 26	-	–	–	–	–
Annual Revenue	Dec 31, 25	$3.24B	+8.8%	-82.2%	+489.1%	–
Annual EPS	Dec 31, 25	-$5.30	-77.2%	-113.4%	-7710.9%	–
	Dec 31, 25	-$733.01M	-5.3%	-104.6%	-141.2%	–
Annual Net Income	Dec 31, 25	-$1.28B	-78.2%	-112.9%	-7500.6%	–

EBITDA Highs

BNTX Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$16.10B	N/A	-101.9%
5Y	$20.93B	Dec 31, 21	-101.4%
All	$20.93B	Dec 31, 21	-101.4%

EBITDA Lows

BNTX Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	-$373.62M	Dec 31, 24	+19.4%
5Y	-$373.62M	Dec 31, 24	+19.4%
All	-$373.62M	Dec 31, 24	+19.4%

EBITDA History

Year	Value	Change
2025	-$300.99M	+19.4%
2024	-$373.62M	-131.7%
2023	$1.18B	-92.7%
2022	$16.10B	-23.1%
2021	$20.93B	+8,159.2%

Year	Value	Change
2020	-$259.75M	-55.1%
2019	-$167.49M	-288.5%
2018	-$43.12M	+27.7%
2017	-$59.61M	-

FAQ

What is the current annual EBITDA of BNTX?: As of today, BNTX annual EBITDA is -$300.99M
What is 1-year change in BNTX annual EBITDA?: BNTX annual EBITDA is up +19.44% year-over-year
What is 3-year change in BNTX annual EBITDA?: BNTX annual EBITDA is down -101.87% over the past 3 years
How far is BNTX annual EBITDA from its all-time high?: BNTX annual EBITDA is currently -101.44% below its historical high of $20.93B set on December 31, 2021
How does BNTX annual EBITDA rank versus sector peers?: BNTX annual EBITDA is higher than 4.15% of companies in Healthcare sector
When is BNTX next annual earnings release?: As of today, the next annual earnings release for BNTX has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

-$551.24M$80.29M+12.71%

June 30, 2026

Summary

Current Value: As of today, BNTX quarterly EBITDA is -$551.24M, up +12.71% on June 30, 2026
Historical Performance: BNTX quarterly EBITDA is up +1.89% year-over-year, down -6.07% over the past 3 years
All-Time High Comparison: BNTX quarterly EBITDA is currently -110.26% below its historical high of $5.37B set on September 30, 2021
3-Year Low Comparison: BNTX quarterly EBITDA is +21.17% above its 3-year low of -$699.32M reached on June 30, 2024
Sector Comparison: BNTX quarterly EBITDA is higher than 0.19% of companies in Healthcare sector

Performance

BNTX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jun 30, 26	-$551.24M	+12.7%	+1.9%	-6.1%	-110.9%
Annual EBITDA	Dec 31, 25	-$300.99M	–	+19.4%	-101.9%	-15.9%
TTM EBITDA	Jun 30, 26	-$373.29M	+2.8%	-49.1%	-106.1%	-105.5%
Price	Aug 27, 26	$111.40	+19.2%	+9.3%	-7.7%	-68.9%
PE Ratio	Aug 27, 26	-	–	–	–	–
Quarterly Revenue	Jun 30, 26	$122.78M	-11.1%	-58.5%	-32.7%	-98.1%
Quarterly EPS	Jun 30, 26	-$3.80	-54.4%	-108.4%	-339.6%	-129.3%
	Jun 30, 26	-$860.64M	-11.3%	-38.9%	-55.2%	-117.2%
Quarterly Net Income	Jun 30, 26	-$954.35M	-53.4%	-117.8%	-360.6%	-128.4%

Quarterly EBITDA Highs

BNTX Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$888.62M	Sep 30, 25	-162.0%
3Y	$888.62M	Sep 30, 25	-162.0%
5Y	$5.37B	Sep 30, 21	-110.3%
All	$5.37B	Sep 30, 21	-110.3%

Quarterly EBITDA Lows

BNTX Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	-$631.53M	Mar 31, 26	+12.7%
3Y	-$699.32M	Jun 30, 24	+21.2%
5Y	-$699.32M	Jun 30, 24	+21.2%
All	-$699.32M	Jun 30, 24	+21.2%

Quarterly EBITDA History

Month	Value	Change
Jun 2026	-$551.24M	+12.7%
Mar 2026	-$631.53M	-697.9%
Dec 2025	-$79.15M	-108.9%
Sep 2025	$888.62M	+258.2%
Jun 2025	-$561.85M	-5.8%
Mar 2025	-$530.86M	-235.2%
Dec 2024	$392.54M	-12.7%
Sep 2024	$449.85M	+164.3%
Jun 2024	-$699.32M	-36.1%
Mar 2024	-$513.70M	-170.8%
Dec 2023	$725.37M	+465.1%
Sep 2023	$128.36M	+124.7%
Jun 2023	-$519.68M	-164.9%
Mar 2023	$801.27M	-77.4%
Dec 2022	$3.55B	+56.8%
Sep 2022	$2.26B	+10.8%

Month	Value	Change
Jun 2022	$2.04B	-61.4%
Mar 2022	$5.29B	+1.6%
Dec 2021	$5.21B	-3.1%
Sep 2021	$5.37B	+6.6%
Jun 2021	$5.04B	+167.4%
Mar 2021	$1.88B	+9,082.4%
Dec 2020	$20.52M	+109.4%
Sep 2020	-$217.30M	-173.6%
Jun 2020	-$79.44M	-41.3%
Mar 2020	-$56.21M	-4.7%
Dec 2019	-$53.69M	-129.0%
Sep 2019	-$23.45M	+46.5%
Jun 2019	-$43.85M	-16.7%
Mar 2019	-$37.57M	-558.5%
Dec 2018	$8.19M	+143.2%
Sep 2018	-$18.96M	-

FAQ

What is the current quarterly EBITDA of BNTX?: As of today, BNTX quarterly EBITDA is -$551.24M
What is BNTX quarterly EBITDA most recent change?: BNTX quarterly EBITDA was up +12.71% on June 30, 2026
What is 1-year change in BNTX quarterly EBITDA?: BNTX quarterly EBITDA is up +1.89% year-over-year
How far is BNTX quarterly EBITDA from its all-time high?: BNTX quarterly EBITDA is currently -110.26% below its historical high of $5.37B set on September 30, 2021
How does BNTX quarterly EBITDA rank versus sector peers?: BNTX quarterly EBITDA is higher than 0.19% of companies in Healthcare sector
When is BNTX next earnings release?: The next earnings release for BNTX is on November 3, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

-$373.29M$10.61M+2.76%

June 30, 2026

Summary

Current Value: As of today, BNTX TTM EBITDA is -$373.29M, up +2.76% on June 30, 2026
Historical Performance: BNTX TTM EBITDA is down -49.13% year-over-year, down -106.13% over the past 3 years
All-Time High Comparison: BNTX TTM EBITDA is currently -101.79% below its historical high of $20.91B set on March 31, 2022
3-Year Low Comparison: BNTX TTM EBITDA is +3.74% above its 3-year low of -$387.78M reached on March 31, 2025
Sector Comparison: BNTX TTM EBITDA is higher than 3.04% of companies in Healthcare sector

Performance

BNTX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jun 30, 26	-$373.29M	+2.8%	-49.1%	-106.1%	-105.5%
Annual EBITDA	Dec 31, 25	-$300.99M	–	+19.4%	-101.9%	-15.9%
Quarterly EBITDA	Jun 30, 26	-$551.24M	+12.7%	+1.9%	-6.1%	-110.9%
Price	Aug 27, 26	$111.40	+19.2%	+9.3%	-7.7%	-68.9%
PE Ratio	Aug 27, 26	-	–	–	–	–
TTM Revenue	Jun 30, 26	$3.09B	-5.3%	-1.1%	-67.1%	-67.0%
TTM EPS	Jun 30, 26	-$7.85	-33.7%	-390.4%	-144.1%	-141.2%
	Jun 30, 26	-$1.16B	-26.2%	-100.8%	-119.5%	-117.4%
TTM Net Income	Jun 30, 26	-$1.97B	-35.6%	-415.3%	-144.1%	-140.0%

TTM EBITDA Highs

BNTX TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$188.45M	Sep 30, 25	-298.1%
3Y	$6.09B	N/A	-106.1%
5Y	$20.91B	Mar 31, 22	-101.8%
All	$20.91B	Mar 31, 22	-101.8%

TTM EBITDA Lows

BNTX TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	-$383.90M	Mar 31, 26	+2.8%
3Y	-$387.78M	Mar 31, 25	+3.7%
5Y	-$387.78M	Mar 31, 25	+3.7%
All	-$406.63M	Sep 30, 20	+8.2%

TTM EBITDA History

Month	Value	Change
Jun 2026	-$373.29M	+2.8%
Mar 2026	-$383.90M	-35.5%
Dec 2025	-$283.24M	-250.3%
Sep 2025	$188.45M	+175.3%
Jun 2025	-$250.32M	+35.4%
Mar 2025	-$387.78M	-4.6%
Dec 2024	-$370.62M	-880.7%
Sep 2024	-$37.79M	+89.5%
Jun 2024	-$359.28M	-100.0%
Mar 2024	-$179.64M	-115.8%
Dec 2023	$1.14B	-71.3%
Sep 2023	$3.96B	-35.0%
Jun 2023	$6.09B	-29.6%
Mar 2023	$8.65B	-34.2%
Dec 2022	$13.14B	-11.2%
Sep 2022	$14.80B	-17.4%

Month	Value	Change
Jun 2022	$17.91B	-14.3%
Mar 2022	$20.91B	+19.5%
Dec 2021	$17.50B	+42.1%
Sep 2021	$12.31B	+83.1%
Jun 2021	$6.73B	+318.2%
Mar 2021	$1.61B	+583.8%
Dec 2020	-$332.42M	+18.2%
Sep 2020	-$406.63M	-91.1%
Jun 2020	-$212.78M	-20.1%
Mar 2020	-$177.19M	-11.8%
Dec 2019	-$158.55M	-64.0%
Sep 2019	-$96.67M	-4.9%
Jun 2019	-$92.18M	-90.7%
Mar 2019	-$48.33M	-349.0%
Dec 2018	-$10.76M	+43.2%
Sep 2018	-$18.96M	-

FAQ

What is the current TTM EBITDA of BNTX?: As of today, BNTX TTM EBITDA is -$373.29M
What is BNTX TTM EBITDA most recent change?: BNTX TTM EBITDA was up +2.76% on June 30, 2026
What is 1-year change in BNTX TTM EBITDA?: BNTX TTM EBITDA is down -49.13% year-over-year
How far is BNTX TTM EBITDA from its all-time high?: BNTX TTM EBITDA is currently -101.79% below its historical high of $20.91B set on March 31, 2022
How does BNTX TTM EBITDA rank versus sector peers?: BNTX TTM EBITDA is higher than 3.04% of companies in Healthcare sector
When is BNTX next earnings release?: The next earnings release for BNTX is on November 3, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

BNTX Official Website www.biontech.de
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1776985/000177698526000017/0001776985-26-000017-index.htm
BNTX Profile on Yahoo Finance finance.yahoo.com/quote/BNTX
BNTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bntx